Advantages of ethanol dilution method for preparing GALA-modified liposomal siRNA carriers on the in vivo gene knockdown efficiency in pulmonary endothelium-Reference-Cited by-同舟云学术

Advantages of ethanol dilution method for preparing GALA-modified liposomal siRNA carriers on the in vivo gene knockdown efficiency in pulmonary endothelium

Published:2014-10 Issue:1-2 Volume:473 Page:144-147
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Kusumoto Kenji^ORCID,Akita Hidetaka,Santiwarangkool Sarochin^ORCID,Harashima Hideyoshi

Funder

Funding Program for Next Generation World-Leading Researchers

Special Education and Research Expenses of the Ministry of Education, Culture, Sports, Science and Technology of Japan

Asahi Glass Foundation

The Uehara Memorial Foundation

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference22 articles.

1. Development of lipidoid-siRNA formulations for systemic delivery to the liver;Akinc;Mol. Ther.,2009

2. Intracellular localization of lipoplexed siRNA in vascular endothelial cells of different mouse tissues;Aleku;Microvasc. Res.,2008

3. Accumulation of sub-100nm polymeric micelles in poorly permeable tumours depends on size;Cabral;Nat. Nanotechnol.,2011

4. Primary pulmonary hypertension;Gaine;Lancet,1998

5. Systemic delivery of siRNA to tumors using a lipid nanoparticle containing a tumor-specific cleavable PEG-lipid;Hatakeyama;Biomaterials,2011

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CRISPR/Cas9 Genome Editing for Tissue‐Specific In Vivo Targeting: Nanomaterials and Translational Perspective;Advanced Science;2023-05-11

2. Treating Pulmonary Fibrosis with Non-Viral Gene Therapy: From Bench to Bedside;Pharmaceutics;2022-04-07

3. Cell-Penetrating Peptides: Emerging Tools for mRNA Delivery;Pharmaceutics;2021-12-29

4. Viral Mimicry as a Design Template for Nucleic Acid Nanocarriers;Frontiers in Chemistry;2021-03-10

5. GALA-Modified Lipid Nanoparticles for the Targeted Delivery of Plasmid DNA to the Lungs;Molecular Pharmaceutics;2021-01-25